The Supreme Court meant what it said in China Agritech, Inc. v. Resh – that is the primary lesson from the First Circuit’s January 30 th decision in In re Celexa and Lexapro Marketing and Sales ...

Just weeks after prosecutors accused Forest Laboratories Inc. of illegally marketing its anti-depressants Celexa and Lexapro to children and paying pediatricians kickbacks, U.S. health regulators have ...

Employees of Forest Labs and that company's rivals should read the U.S. government's complaint against the company, which alleges off-label promotion of Lexapro and Celexa for use in children. The ...

Forest Labs is holding a $170 million contingency fee in case it needs to settle allegations by the Department of Justice that it bribed doctors --- with such things as $1,000 gift certificates to ...

WASHINGTON – Forest Pharmaceuticals Inc. has agreed to pay more than $313 million and plead guilty to obstruction of justice, distribution of the then-unapproved drug Levothroid and illegal promotion ...

The U.S. Department of Justice has filed a complaint against Forest Laboratories, the maker of antidepressants Celexa and Lexapro, accusing it of being underhanded in how it disclosed its research.

ST. LOUIS (CN) – Forest Pharmaceuticals and Forest Laboratories illegally marketed two antidepressant drugs, Celexa and Lexapro, a class action claims in Federal Court. Named plaintiffs ...